FDA Inspection
NORTON (WATERFORD) LIMITEDNORTON (WATERFORD) LIMITED – FDA Inspection, Feb 16, 2018
Record Details
This FDA Inspection record concerns NORTON (WATERFORD) LIMITED, with an inspection on February 16, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · d586fe48-fc40-4b8e-98bb-b17f896248a3
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1044616
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of NORTON (WATERFORD) LIMITED
8| Date | Classification | Office | Project area |
|---|---|---|---|
| July 29, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 24, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 10, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 12, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 29, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for NORTON (WATERFORD) LIMITED
- FDA Inspection 1265747 - 2022-07-29
- FDA Inspection 1143438 - 2020-01-24
- FDA Inspection 945753 - 2015-09-10
- FDA Inspection 854583 - 2013-09-12
- FDA Inspection 750358 - 2011-09-29
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.